Evelo Biosciences Inc. (NASDAQ: EVLO) At $2.00 Is Worth A Gamble – Marketing Sentinel
Home  »  Technologies   »  Evelo Biosciences Inc. (NASDAQ: EVLO) At $2.00 Is ...

Evelo Biosciences Inc. (NASDAQ: EVLO) At $2.00 Is Worth A Gamble

During the last session, Evelo Biosciences Inc. (NASDAQ:EVLO)’s traded shares were 1.12 million, with the beta value of the company hitting 1.74. At the end of the trading day, the stock’s price was $2.00, reflecting an intraday gain of 9.29% or $0.17. The 52-week high for the EVLO share is $17.12, that puts it down -756.0 from that peak though still a striking 29.0% gain since the share price plummeted to a 52-week low of $1.42. The company’s market capitalization is $205.00M, and the average intraday trading volume over the past 10 days was 0.33 million shares, and the average trade volume was 330.57K shares over the past three months.

Evelo Biosciences Inc. (EVLO) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 2.00. EVLO has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.43.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Evelo Biosciences Inc. (NASDAQ:EVLO) trade information

Evelo Biosciences Inc. (EVLO) registered a 9.29% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.29% in intraday trading to $2.00 this Wednesday, 06/22/22, hitting a weekly high. The stock’s 5-day price performance is 3.09%, and it has moved by 9.29% in 30 days. Based on these gigs, the overall price performance for the year is -87.56%. The short interest in Evelo Biosciences Inc. (NASDAQ:EVLO) is 7.39 million shares and it means that shorts have 25.74 day(s) to cover.

The consensus price target of analysts on Wall Street is $13.00, which implies an increase of 84.62% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $20.00 respectively. As a result, EVLO is trading at a discount of -900.0% off the target high and -200.0% off the low.

Evelo Biosciences Inc. (EVLO) estimates and forecasts

Statistics show that Evelo Biosciences Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Evelo Biosciences Inc. (EVLO) shares have gone down -73.75% during the last six months, with a year-to-date growth rate more than the industry average at 10.67% against 0.60. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 27.10% this quarter and then jump 31.70% in the quarter after that.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -37.50%. While earnings are projected to return 2.70% in 2022.

EVLO Dividends

Evelo Biosciences Inc. is due to release its next quarterly earnings between July 27 and August 01. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Evelo Biosciences Inc. (NASDAQ:EVLO)’s Major holders

Evelo Biosciences Inc. insiders own 0.13% of total outstanding shares while institutional holders control 71.95%, with the float percentage being 72.04%. Flagship Pioneering Inc. is the largest shareholder of the company, while 108 institutions own stock in it. As of Mar 30, 2022, the company held over 23.03 million shares (or 42.92% of all shares), a total value of $78.07 million in shares.

The next largest institutional holding, with 8.05 million shares, is of FMR, LLC’s that is approximately 15.00% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $27.28 million.

Also, the Mutual Funds coming in first place with the largest holdings of Evelo Biosciences Inc. (EVLO) shares are Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund. Data provided on Apr 29, 2022 indicates that Fidelity Growth Company Fund owns about 2.58 million shares. This amounts to just over 4.81 percent of the company’s overall shares, with a $6.37 million market value. The same data shows that the other fund manager holds slightly less at 0.93 million, or about 1.73% of the stock, which is worth about $3.15 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts